CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-06 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 907,155 | ||
| 2023-04-05 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-04-05 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −6,666 | $152.74 | $1.0M | 5,445,280 |
| 2023-04-05 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −2,934 | $153.66 | $451K | 5,442,346 |
| 2023-04-05 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −22,533 | $155.01 | $3.5M | 5,419,813 |
| 2023-04-05 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −7,754 | $155.54 | $1.2M | 5,412,059 |
| 2023-04-05 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −113 | $156.50 | $18K | 5,411,946 |
| 2023-04-05 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 947,155 | ||
| 2023-03-30 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-03-30 | Bancel Stephane Chief Executive Officer | Sale | −13,900 | $147.13 | $2.0M | 5,438,046 |
| 2023-03-30 | Bancel Stephane Chief Executive Officer | Sale | −2,979 | $148.24 | $442K | 5,435,067 |
| 2023-03-30 | Bancel Stephane Chief Executive Officer | Sale | −15,965 | $149.39 | $2.4M | 5,419,102 |
| 2023-03-30 | Bancel Stephane Chief Executive Officer | Sale | −7,156 | $149.99 | $1.1M | 5,411,946 |
| 2023-03-30 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 987,155 | ||
| 2023-03-29 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-03-29 | Bancel Stephane Chief Executive Officer | Sale | −31,349 | $148.21 | $4.6M | 5,420,597 |
| 2023-03-29 | Bancel Stephane Chief Executive Officer | Sale | −8,300 | $148.83 | $1.2M | 5,412,297 |
| 2023-03-29 | Bancel Stephane Chief Executive Officer | Sale | −351 | $149.72 | $53K | 5,411,946 |
| 2023-03-29 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,027,155 | ||
| 2023-03-23 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
Page 51 of 66 · 1,314 trades